PRP treatment can be effective for hair loss.
173 citations
,
July 2012 in “British Journal of Dermatology” Dabrafenib can cause skin growths and sometimes low-grade skin cancer.
28 citations
,
February 2012 in “PLoS ONE” A PKP1 gene mutation causes skin fragility and hair loss in Chesapeake Bay retriever puppies.
5 citations
,
April 2017 in “Dermatologic Surgery” PRP treatment satisfies 58% of female hair loss patients, with most noticing fuller, thicker hair and less shedding.
87 citations
,
February 2019 in “Tissue Engineering Part B Reviews” Platelet-rich plasma can effectively treat and prevent tissue infections.
169 citations
,
January 2020 in “Burns & Trauma” Platelet-rich plasma speeds up skin wound healing.
15 citations
,
January 2016 in “Sustainable development and biodiversity” Using PGPR as biofertilizers can improve soil health and plant growth while reducing reliance on synthetic fertilizers.
1 citations
,
January 2010 in “Institutional Repository of Leibniz Universität Hannover (Leibniz Universität Hannover)”
September 2021 in “VNU Journal of Science: Medical and Pharmaceutical Sciences” Platelet-rich plasma, which has growth factors, is used in many medical fields and can promote tissue repair, stimulate hair growth, and increase hair density.
December 2020 in “The journal of investigative dermatology/Journal of investigative dermatology” Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.
3 citations
,
March 2022 in “PubMed” PRP may help treat scarring hair loss from discoid lupus.
34 citations
,
January 2022 in “Human Reproduction Open” PRP injections did not significantly improve ovarian function in women with low ovarian reserve.
January 2020 in “Hair therapy & transplantation” PRP therapy can help stimulate natural hair growth and thicken hair.
December 2025 in “Animals” TGFBR1 slows down cell growth in fine-wool sheep hair follicles.
August 2024 in “DergiPark (Istanbul University)” Platelet-rich plasma treatment shows early improvement in femoral head avascular necrosis.
July 2024 in “Journal of Investigative Dermatology” CRISPR/Cas9 and prime editing can potentially fix skin disorder genes safely and effectively.
March 2025 in “Human Movement” PRP might help athletes' injuries, but more research is needed.
April 2023 in “The Egyptian Journal of Hospital Medicine” Injecting platelet-rich plasma is a safe and effective way to improve different types of post-burn scars.
August 2020 in “Universidad Peruana de Ciencias Aplicadas (UPC)” Platelet-rich plasma (PRP) effectively improves acne scars.
February 2022 in “Programa de Iniciação Científica - PIC/UniCEUB - Relatórios de Pesquisa” PRP is more effective than Minoxidil for reducing hair loss and promoting hair growth.
December 1981 in “ビジネスコミュニケ-ション” TRPV1 affects sebaceous gland function and could help treat acne.
January 2026 in “Journal of Advances in Medicine and Medical Research” Adding Platelet-Rich Plasma to hair implantation improves hair growth and graft survival.
September 2003 in “Hair transplant forum international” A Brazilian Hair Restoration Surgery Society has been established.
12 citations
,
January 2001 in “Der Hautarzt” Trichorhinophalangeal syndrome causes hair, facial, and bone issues, with no specific treatment beyond gentle care.
15 citations
,
August 2019 in “Dermatologic Therapy” Platelet-rich plasma (PRP) may help treat hair loss in patients with frontal fibrosing alopecia who don't respond to other treatments.
January 2021 in “Springer eBooks” PRP might help with hair growth, but its effectiveness in hair transplants is unclear.
September 2023 in “HAL (Le Centre pour la Communication Scientifique Directe)” Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.
December 2024 in “Biological and Clinical Sciences Research Journal” Injectable platelet-rich fibrin (I-PRF) is more effective than platelet-rich plasma (PRP) for treating hair loss.
1 citations
,
April 2024 in “PubMed” Photobiomodulation is effective and safe for healing injuries and improving appearance.
March 2026 in “Folia Histochemica et Cytobiologica” LTBP1 is a key regulator in diseases and a potential target for new treatments.